Akif Erdoğan is an R&D Formulation Manager with expertise in developing generic pharmaceuticals for the USFDA, EMA, and Turkish markets. He specializes in strategic molecule selection, formulation optimization, and bioequivalence study design. Currently pursuing a PhD in Pharmaceutical Technology, he is also focused on advancing innovative dosage forms